In vivo confocal microscopic evaluation of corneal Langerhans cell density, and distribution and evaluation of dry eye in rheumatoid arthritis

Innate Immunity

Volumn 19, Issue 4, 2013, Pages 348-354

  Marsovszky, László ^a   Resch, Miklós D ^a   Németh, János ^a   Toldi, Gergely ^a   Medgyesi, Erzsébet ^b   Kovács, László ^b   Balog, Attila ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Anti TNF therapy; corneal Langerhans cell; in vivo confocal microscopy; rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ARTICLE; CELL DENSITY; CELL STRUCTURE; CONFOCAL LASER MICROSCOPY; CONJUNCTIVA; CONTROLLED STUDY; DAS28; DENDRITIC CELL; DISEASE ACTIVITY; DRUG EFFECT; DRY EYE; FEMALE; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; KERATITIS; LACRIMATION; LANGERHANS CELL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OCULAR SURFACE DISEASE INDEX QUESTIONNAIRE; QUESTIONNAIRE; REMISSION; RHEUMATOID ARTHRITIS; SCHIRMER TEST; TEAR BREAK UP TIME; TREATMENT OUTCOME; VISUAL SYSTEM PARAMETERS;

ANTI-TNF THERAPY; CORNEAL LANGERHANS CELL; IN VIVO CONFOCAL MICROSCOPY; RHEUMATOID ARTHRITIS;

AGED; ANTIBODIES, BLOCKING; ARTHRITIS, RHEUMATOID; CELL COUNT; CORNEA; DISEASE PROGRESSION; DRY EYE SYNDROMES; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNITY, INNATE; LANGERHANS CELLS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880323419     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912461677     Document Type: Article

References (32)

1. Lemp MA. Dry eye (keratoconjunctivitis sicca), rheumatoid arthritis, and Sjögren's syndrome. Am J Ophthalmol. 2005 ; 140: 898-899
2. Resch MD, Imre L, Tapasztó B, Németh J. Confocal microscopic evidence of increased Langerhans cell activity after corneal metal foreign body removal. Eur J Ophthalmol. 2008 ; 18: 703-707
3. Zhivov A, Stave J, Vollmar B, Guthoff R. In vivo confocal microscopic evaluation of Langerhans cell density and distribution in the corneal epithelium of healthy volunteers and contact lens wearers. Cornea. 2007 ; 26: 47-54
4. Hamrah P, Liu Y, Zhang Q, Dana MR. Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol. 2003 ; 121: 1132-1140
5. Seto SK, Gillette TE, Chandler JW. HLA-DR+/T6- Langerhans cells of the human cornea. Invest Ophthalmol Vis Sci. 1987 ; 28: 1719-1722
6. Zhivov A, Stave J, Vollmar B, Guthoff R. In vivo confocal microscopic evaluation of Langerhans cells density and distribution in the normal corneal epithelium. Graefe's Arch Clin Exp Ophthalmol. 2005 ; 243: 1056-1061
7. Hamrah P, Dana MR. Corneal antigen-presenting cells. Chem Immunol Allergy. 2007 ; 92: 58-70
8. Kawamoto K, Chikama T, Takahashi N, Nishida T. In vivo observation of Langerhans cells by laser confocal microscopy in Thygeson's superficial punctate keratitis. Mol Vis. 2009 ; 29: 1456-1462
9. Su PY, Hu FR, Chen YM, Han JH, Chen WL. Dendritiform cells found in central cornea by in-vivo confocal microscopy in a patient with mixed bacterial keratitis. Ocul Immunol Inflamm. 2006 ; 14: 241-244
10. Dekaris I, Zhu SN, Dana MR. TNF-alpha regulates corneal Langerhans cell migration. J Immunol. 1999 ; 162: 4235-4239
11. Niederkorn JY, Peeler JS, Mellon J. Phagocytosis of particulate antigens by corneal epithelial cells stimulate interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg Immunol. 1989 ; 2: 83-90
12. Minsky M. Memoir on inventing the confocal scanning microscope. Scanning. 1988 ; 10: 128-138
13. Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 ; 62: 2569-2581
14. Vitali C, Bombardieri S, Jonsson R, et al. European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 ; 61: 554-558
15. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000 ; 118: 615-621
16. Pult H, Purslow C, Murphy PJ. The relationship between clinical signs and dry eye symptoms. Eye. 2011 ; 25: 502-510
17. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology. 1982 ; 89: 700-711
18. Hamrah P, Huq OS, Liu Y, et al. Corneal immunity is mediated by heterogenous population of antigen-presenting cells. J Leukoc Biol. 2003 ; 73: 172-178
19. Zhivov A, Kraak R, Bergter H, et al. Influence of benzalkonium chloride on Langerhans cells in corneal epithelium and development of dry eye in healthy volunteers. Curr Eye Res. 2010 ; 35: 762-769
20. Chen W, Lin H, Dong N, et al. Cauterization of central cornea induces recruitment of major histocompatibility complex class II + Langerhans cells from limbal basal epithelium. Cornea. 2010 ; 29: 73-79
21. Lin H, Li W, Dong N, et al. Changes in corneal epithelial layer inflammatory cells in aqueous tear-deficient dry eye. Invest Ohpthalmol Vis Sci. 2010 ; 51: 122-128
22. Villani E, Beretta S, De Capitani M, et al. In vivo confocal microscopy of meibomian glands in Sjögren's syndrome. Invest Ophthalmol Vis Sci. 2011 ; 52: 933-939
23. Imre L, Nagymihály A. Reliability and reproducibility of corneal endothelial image analysis by in vivo confocal microscopy. Graefes Arch Clin Exp Ophtalmol. 2001 ; 239: 356-360
24. Dana R, Dai R, Zu S, et al. Wayne. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege. Invest Ohpthalmol Vis Sci. 1998 ; 39: 70-77
25. Dana R. Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007 ; 105: 330-343
26. Erdélyi B, Kraak R, Zhivov A, et al. In vivo confocal laser scanning microscopy of the cornea in dry eye. Graefes Arch Clin Exp Ophthalmol. 2007 ; 245: 39-44
27. Villani E, Galimberti D, Viola F, et al. Corneal involvement in rheumatoid artritis: an in vivo confocal study. Invest Ohpthalmol Vis Sci. 2008 ; 49: 560-564
28. Pitcher JD 3rd, De Paiva CS, Pelegrino FS, et al. Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland. Invest Ophthalmol Vis Sci. 2011 ; 52: 3221-3227
29. Massingale ML, Li X, Vallabhajosyula M, et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009 ; 28: 1023-1027
30. Fujita M, Igarashi T, Kurai T, et al. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. 2005 ; 140: 808-813
31. Stern ME, Wheeler LA, Niederkorn JY, et al. Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol. 2011 ; 187: 3653-3662
32. Kavousanaki M, Makrigiannakis A, Boumpas D, Verginis P. Novel role of plasmocytoid dendritic cells in human induction of interleukin-10 producing Treg cells by plasmocytoid dendritic cells in patients with rheumatoid arthritis responding to therapy. Arthritis Rheum. 2010 ; 62: 53-63